In Section A, contributors will acquire distinct doses and schedules of oral ABBV-744 pill to identify Risk-free dosing program. Additional individuals are going to be enrolled on the determined monotherapy dosign routine. In Section B, members will acquire oral ruxolitinib and ABBV-744 will be presented as "increase-on" therapy. In Phase https://cruziryfo.creacionblog.com/31958485/top-guidelines-of-abbv-744-safety-and-side-effects